Renee Brissette is a HuCAL Technical Sales Specialist at Bio-Rad Laboratories (USA), having joined the team in 2017. In her current role, she is responsible for designing and delivering high performance custom antibodies using the HuCAL technology. Previous to Bio-Rad, Renee worked at DGI Biotechnologies where she constructed antibody and peptide phage display libraries and developed panning strategies to generate drug leads against novel cancer targets. Renee received her PhD in biochemistry from UMDNJ-New Jersey Medical School (USA) then studied model signal transduction and transcriptional regulator systems in bacteria at Rutgers Medical School (USA) as a postdoctoral fellow. This research led to several significant publications to elucidate the mechanism of signal transduction across membranes by demonstrating the functionality of a chimeric receptor in bacteria.